Labcorp expands in specialty testing and ramps up acquisitions, but macro pressures and currency headwinds complicate its growth outlook.

The custom antibody market is projected to grow at a CAGR of roughly 10% over the forecast period. This expansion is fueled ...

It has been about a month since the last earnings report for Labcorp Holdings (LH). Shares have added about 8.1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

Gilead Sciences hired Bristol Myers Squibb alum Bob Allen as head of omnichannel strategy and digital transformation for public affairs. Ralph Abraham, who is Louisiana ‘s surgeon general, has been ...

While Labcorp Holdings has underperformed the S&P 500 Index slightly over the past year, its YTD strength stands out.